Newsfeeds

HOT NEWS

LEVITRA 10mg Orodispersible Tablet for the Treatment of Erectile Dysfunction app... » The European Commission has approved a new formulation of Levitra® (vardenafil HCI). Levitra 10mg o...

BBC Panorama: "A Risk Worth Taking?" Programme. GlaxoSmithKline Right of Reply S... » Patient safety is our first priority. We strongly refute any allegation that our actions have put pa...

Reports of narcolepsy in Europe following vaccination with Pandemrix™ » GSK initially became aware of possible cases of narcolepsy following vaccination with the adjuvanted...

European Commission Issues Positive Decision for Approval of Seroquel XR » AstraZeneca announced that the European Commission (EC) has issued a positive decision for the appro...

Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC » Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from t...

Global market launch of Daxas® (Roflumilast) kicks off in Germany » Stefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas® ...

A new era for patients with atrial fibrillation - Dabigatran etexilate at the fo... » The European Society of Cardiology (ESC) issued revised practice guidelines for the management of at...

Genetic substudy shows fewer major cardiovascular events with ticagrelor (BRILIN... » A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that th...

Shire Announces European Approval of VPRIV® (velaglucerase alfa) » Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today...

Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial ... » Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from...

Newsfeeds

Breaking World Pharma News

World Pharma News - one of the world's leading web-based pharmaceutical news publications - is committed to providing and disseminating the most prominent pharmaceutical news and achievements.

Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication SAPHRIS®
Merck announced that the U.S. Food and Drug Administration (FDA) has approved two supplemental new drug applications (sNDA's) for SAPHRIS® (asenapine) sublingual tablets to expand the product's indications.
Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
Abbott (NYSE: ABT) has completed its acquisition of Piramal's Healthcare Solutions business, propelling it to market leadership in the Indian pharmaceutical market and further accelerating the company's growth in emerging markets.
Bristol-Myers Squibb to Acquire ZymoGenetics
Bristol-Myers Squibb Company (NYSE:BMY) and ZymoGenetics, Inc. (NASDAQ: ZGEN) announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.
Roche announces Operational Excellence initiative
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of a Group-wide Operational Excellence initiative. In view of mounting pressures to curb healthcare costs - especially in the United States and Europe - together with recent developments in late-stage projects in the Roche pipeline, this initiative aims to adapt cost structures and accelerate productivity improvements Group-wide.
BBC Panorama: "A Risk Worth Taking?" Programme. GlaxoSmithKline Right of Reply Statement
Patient safety is our first priority. We strongly refute any allegation that our actions have put patients at risk. We have carried out an extensive research programme, involving more than 50,000 patients to analyse the safety and benefits of Avandia.
Clinical Trials 2010 - Invest up to 50% less and be among the experts from the industry
29 - 30 September 2010, Frankfurt, Germany.
In the current environment where minimising cost and delivering ROI are critical themes within the pharma industry, improving your clinical trial infrastructure can ensure that time is not wasted and you are maximising your investments.
Pharma Marketing 2010 - Invest up to 50% less and be among the experts from the industry
30 September 2010, Frankfurt, Germany.
Pharma Marketing 2010 in Frankfurt provides a key platform for Europe's pharmaceutical industry stakeholders, such as yourself, to discover how best to tackle the key challenges of a price-sensitive and increasingly competitive and rapidly changing market.
Novartis and collaborators discover novel antimalarial drug candidate
Novartis announced that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel compound that shows promise as a next generation treatment for drug resistant malaria.
Reports of narcolepsy in Europe following vaccination with Pandemrix™
GSK initially became aware of possible cases of narcolepsy following vaccination with the adjuvanted H1N1 pandemic vaccine Pandemrix through adverse event reports received by the Swedish Medical Products Agency, and subsequently via media reports in Finland.
Merck's Cladribine Tablets for Multiple Sclerosis Approved in Australia
Merck KGaA announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS). Cladribine Tablets will be registered in Australia under the trade name Movectro®.

All PharmaNews.eu RSS Channels

Latest News

Industry News

Sponsored Links

Who's Online

Latest News

Industry News

More information